Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -5.496% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) CCOc1ccc(C)cc1CN(CCCl)CCCl.Cl
b.) COc1cccc(Sc2cc(N3CCOCC3)nc(-c3ccccc3)n2)c1
c.) NC(=O)COC(=O)c1ccc(Oc2ccccc2)cc1
Answer: b. COc1cccc(Sc2cc(N3CCOCC3)nc(-c3ccccc3)n2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cccc(Sc2cc(N3CCOCC3)nc(-c3ccccc3)n2)c1
COc1cccc(Sc2cc(N3CCOCC3)nc(-c3ccccc3)n2)c1
4-[6-(3-methoxyphenyl)sulfanyl-2-phenylpyrimidin-4-yl]morpholine